V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190010551 | 190005170 | 1.74 | 59.7 | null | 2017-05-09 | 2017-05-09 | OST Euramos 1 Closed Trial - IE | 02 | N | EW REL REECUR IFOSFAMIDE | 101698758 |
| 190010554 | 190005171 | 1.6 | 83.1 | Palliative (P) | 2018-11-14 | 2018-11-21 | OST Euramos 1 Closed Trial - A | 02 | N | DOXORUBICIN | 101448429 |
| 190010555 | 190005172 | 1.88 | 21 | null | 2019-01-09 | 2019-07-18 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100798334 |
| 190010563 | 190005173 | 1.63 | 57 | Curative (C) | 2017-11-02 | 2018-06-03 | PAM x 2 post-surgery (cycles 3&4) | 2 | null | NB HRNBL-1 ISOTRETINOIN | 101796420 |
| 190010566 | 190005174 | 0 | 29 | Curative (C) | 2018-12-05 | 2019-09-20 | METHOTREXATE | 02 | Y | METHOTREXATE | 101178459 |
| 190010571 | 190005175 | 1.52 | 61.6 | Curative (C) | 2016-04-25 | 2016-11-11 | OST Euramos 1 Closed Trial - M | 02 | null | OST M | 101664435 |
| 190010578 | 190005176 | 1.53 | 84.7 | Adjuvant (A) | 2019-06-11 | 2019-06-15 | MAP + MIFAMURTIDE | 02 | null | NOT MATCHED | 101201115 |
| 190010589 | 190005177 | 1.75 | 49 | null | 2016-09-30 | 2016-10-06 | OST Mifamurtide | 01 | N | OST IE | 100945629 |
| 190010591 | 190005178 | 1.87 | 48.7 | Palliative (P) | 2017-06-29 | 2017-06-29 | EW EuroEwing 2012 Arm B VC | 01 | N | EW EUROEWING 2012 ARM B VC | 101084163 |
| 190010592 | 190005179 | 1.62 | 120 | Curative (C) | 2021-04-24 | 2021-08-26 | OST Euramos 1 Closed Trial - A | 02 | Y | OST A | 100205649 |
| 190010593 | 190005180 | 1.83 | 67.3 | Curative (C) | 2019-12-19 | 2020-01-06 | OST Mifamurtide | 02 | null | CISPLATIN + ETOPOSIDE | 101788187 |
| 190010596 | 190005181 | 1.64 | 66.65 | Curative (C) | 2018-03-14 | 2018-04-11 | Doxorubicin + Olaratumab | Y | N | DOXORUBICIN + METHOTREXATE | 100167309 |
| 190010597 | 190005182 | 1.82 | 27.5 | Palliative (P) | 2017-10-20 | 2018-01-11 | Cyclophosphamide + Vincristine | 02 | Y | TRIAL | 100364039 |
| 190010598 | 190005183 | 1.58 | 52.2 | null | 2018-03-03 | 2018-03-07 | IMATINIB | Y | N | ETOPOSIDE | 101068976 |
| 190010604 | 190005184 | 1.84 | 34.1 | null | 2017-07-04 | 2017-07-12 | Oxaliplatin + Modified de Gramont | 02 | null | TRIAL | 101695167 |
| 190010608 | 190005185 | 1.69 | 63 | Curative (C) | 2019-04-07 | 2019-04-07 | Brentuximab | 02 | null | EW EUROEWING 2012 ARM A VAI | 100535398 |
| 190010609 | 190005186 | 1.57 | 48.4 | null | 2018-01-05 | 2018-01-05 | Doxorubicin + Methotrexate | N | Y | MAP | 100533029 |
| 190010617 | 190005188 | 1.87 | 28 | Neo-adjuvant (N) | 2016-05-31 | 2016-06-12 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 101078269 |
| 190010618 | 190005189 | 1.63 | 52.5 | Curative (C) | 2016-03-20 | 2016-03-24 | ETOPOSIDE + IFOSFAMIDE + MESNA | N | Y | ETOPOSIDE + IFOSFAMIDE | 100180550 |
| 190010621 | 190005190 | 1.6 | 61 | null | 2016-07-14 | 2016-08-04 | Docetaxel + Gemcitabine (prior RT) | 01 | null | DOCETAXEL + GEMCITABINE | 100869513 |
| 190010631 | 190005191 | 1.69 | 71.5 | Neo-adjuvant (N) | 2017-03-23 | 2017-04-18 | METHOTREXATE | N | Y | METHOTREXATE | 101376355 |
| 190010643 | 190005192 | null | 62 | null | 2018-05-18 | 2019-05-22 | Etoposide + Ifosfamide + HD Mtx | 02 | N | CISPLATIN + FLUOROURACIL | 100166300 |
| 190010645 | 190005193 | 1.89 | 115 | Neo-adjuvant (N) | 2019-06-18 | 2019-09-16 | EW EuroEwing 2012 Arm B VC | 01 | N | EW EUROEWING 2012 ARM B VC | 101482072 |
| 190010650 | 190005194 | 1.6 | 55.2 | Curative (C) | 2017-10-30 | 2018-03-28 | MAP | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100561190 |
| 190010652 | 190005195 | 1.5 | 58.6 | Neo-adjuvant (N) | 2017-11-05 | 2017-12-31 | Methotrexate High Dose (3g/m2) | 02 | null | METHOTREXATE | 101381619 |
| 190010658 | 190005196 | 1.75 | 79.3 | null | 2020-02-03 | 2020-02-03 | CAPECITABINE + IRINOTECAN | 02 | N | CISPLATIN + DOXORUBICIN | 101606315 |
| 190010666 | 190005197 | 1.88 | 53.2 | Curative (C) | 2017-04-25 | 2017-05-12 | EW Rel rEECur Irinotecan/Temozolomide | 02 | null | NOT MATCHED | 100673802 |
| 190010672 | 190005198 | 1.68 | 44 | Adjuvant (A) | 2017-03-19 | 2017-04-16 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | N | MAP | 100847315 |
| 190010677 | 190005199 | 1.52 | 55.7 | null | 2018-12-25 | 2019-02-27 | Liposomal Doxorubicin 50mg/m2 | 01 | N | DOXORUBICIN + METHOTREXATE | 101071807 |
| 190010681 | 190005200 | 1.83 | 58.5 | null | null | 2013-12-22 | OST Euramos 1 Closed Trial - IE | null | null | OST MIFAMURTIDE | 101015225 |
| 190010685 | 190005201 | 1.66 | 73.5 | Adjuvant (A) | null | 2017-02-22 | ETOPOSIDE + IFOSFAMIDE | null | null | ETOPOSIDE + IFOSFAMIDE | 101159852 |
| 190010686 | 190005202 | 1.57 | 76.9 | Palliative (P) | 2019-10-06 | 2019-11-02 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 100538535 |
| 190010688 | 190005203 | 1.57 | 49.1 | Neo-adjuvant (N) | 2019-08-07 | 2019-08-20 | Etoposide + Ifosfamide (5 days) | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100330018 |
| 190010689 | 190005204 | 1.89 | 98 | null | 2016-12-10 | 2016-12-25 | Docetaxel + Gemcitabine with GCSF | 02 | N | DOCETAXEL + GEMCITABINE | 101803600 |
| 190010698 | 190005205 | 1.93 | 26.5 | Palliative (P) | 2019-05-04 | 2019-05-08 | NB BEACON Temozolomide Topotecan | 02 | N | CISPLATIN + CYTARABINE | 101530354 |
| 190010707 | 190005207 | 1.56 | 88.4 | Palliative (P) | 2019-11-26 | 2019-12-18 | DOCETAXEL + GEMCITABINE | 01 | N | DOCETAXEL + GEMCITABINE | 101496429 |
| 190010710 | 190005208 | null | 61.5 | Palliative (P) | null | 2021-11-29 | Trial Unspecified | null | null | TRIAL UNSPECIFIED | 101002130 |
| 190010715 | 190005209 | 1.68 | 78.7 | Curative (C) | 2019-05-22 | 2019-12-09 | Liposomal Doxorubicin (Caelyx) | 02 | N | CASPS TRIAL | 101401096 |
| 190010716 | 190005210 | 1.67 | 57 | Curative (C) | 2017-07-18 | 2017-07-20 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 100551431 |
| 190010719 | 190005211 | 1.72 | 105.2 | Curative (C) | 2018-05-18 | 2018-07-04 | ECarboX | 02 | N | EW EUROEWING 2012 ARM A VAI | 100144097 |
| 190010729 | 190005212 | 1.66 | 69 | Curative (C) | 2017-03-26 | 2017-04-12 | Etoposide + Ifosfamide (5 days) | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100411559 |
| 190010736 | 190005213 | 1.8 | 40 | null | 2019-12-24 | 2019-12-28 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100400244 |
| 190010737 | 190005214 | 1.58 | 33.5 | Palliative (P) | 2017-11-07 | 2017-11-08 | Ribociclib | 02 | N | EW EUROEWING 2012 ARM A VAI | 100519151 |
| 190010738 | 190005215 | null | 93.6 | null | 2021-12-27 | 2022-01-07 | EW Rel rEECur Irinotecan/Temozolomide | 02 | N | MAP | 100758274 |
| 190010739 | 190005216 | null | 75.5 | Curative (C) | 2017-04-17 | 2017-07-03 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 100569513 |
| 190010741 | 190005217 | 1.6 | 75.5 | Palliative (P) | 2018-06-22 | 2018-07-19 | Trial Unspecified | N | N | TRIAL UNSPECIFIED | 100422291 |
| 190010749 | 190005218 | 1.63 | 54.5 | Palliative (P) | 2018-01-29 | 2018-06-30 | Paclitaxel 80mg/m2 day 1 8 15 | N | Y | DOXORUBICIN + IFOSFAMIDE | 100967392 |
| 190010755 | 190005219 | 1.74 | 71.8 | Palliative (P) | 2017-02-03 | 2017-02-04 | FLUOROURACIL + IRINOTECAN | 02 | N | STS RHABDO RMS 2005 2ND TOPO CYCLO | 101847115 |
| 190010766 | 190005220 | 1.61 | 67.2 | Palliative (P) | null | 2018-06-24 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 02 | N | EW EUROEWING 2012 ARM A VAI | 101328074 |
| 190010776 | 190005221 | 1.59 | 16.8 | Curative (C) | 2016-11-03 | 2017-03-04 | MAP | 02 | Y | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101547765 |